Brenton Karl Ahrens
Director, Dexcom.
Companies
- Iterum Therapeutics plcBoard member May 24, 2018 to Dec 28, 20221
- DexcomBoard member Apr 17, 2006 to Apr 17, 20062
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Iterum Therapeutics plc410 shares3Sep 20, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 20, 2022Sold 7,246 shares at $1.78 of Iterum Therapeutics plc3
- Sep 19, 2022Sold 15,000 shares at $1.77 of Iterum Therapeutics plc3
- Sep 16, 2022Sold 15,000 shares at $1.90 of Iterum Therapeutics plc3
- Sep 15, 2022Sold 15,000 shares at $2.02 of Iterum Therapeutics plc4
- Sep 14, 2022Sold 15,000 shares at $2.10 of Iterum Therapeutics plc4
- Sep 13, 2022Sold 15,000 shares at $2.14 of Iterum Therapeutics plc4
- Sep 12, 2022Sold 15,000 shares at $2.31 of Iterum Therapeutics plc5
- Sep 9, 2022Sold 15,000 shares at $2.32 of Iterum Therapeutics plc5
- Sep 8, 2022Sold 3,298 shares at $2.26 of Iterum Therapeutics plc5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARDexcom, Board member
- 3
- 4SEC EDGARForm 4 filed Sep 15, 2022
- 5SEC EDGARForm 4 filed Sep 12, 2022